Applications of Genomics Derived Characteristics for Evolutionary and Functional studies and for Development of Novel Diagnostics and Therapeutics
基因组学衍生特征在进化和功能研究以及新型诊断和治疗方法开发中的应用
基本信息
- 批准号:RGPIN-2019-06397
- 负责人:
- 金额:$ 3.42万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2019
- 资助国家:加拿大
- 起止时间:2019-01-01 至 2020-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Microorganisms play vital roles in all aspects of life including recycling of organic materials, nitrogen fixation, photosynthesis, waste decomposition, bioremediation, production of antibiotics and other important compounds, as well as major determinants of human health and diseases. In view of their central roles in health care, agriculture, mining, fishing and other areas, it is important to develop reliable means for distinguishing different groups of microorganisms. However, most of the bacterial groups are currently distinguished from each other only on the basis of their branching in the 16S rRNA trees. As 16S sequence information does not, in itself, provide prediction of phenotypic trait(s) for most groups, no group-specific molecular or biochemical properties are known. For a reliable and comprehensive understanding of the biological properties of diverse groups of microorganisms, it is critically important to identify evolutionarily conserved traits that are uniquely shared by specific groups of interest and which can distinguish them from all others. Genome sequences provide a unique and definitive resource for discovering novel molecular markers that are specific for each group. Using genome sequences, my group has pioneered the discovery of two types of molecular markers, Conserved Signature Indels (CSIs) and Conserved Signature Proteins (CSPs), which are uniquely found in specific groups of organisms. As the genotype specifies phenotype, these molecular markers will provide important means for discovering novel biochemical/biological properties uniquely shared by each group of organisms and for development of novel diagnostics and therapeutics aimed at these organisms. During the next 5 years, our work in this area will use genome sequences to comprehensively investigate three important groups of bacteria viz. Pseudomonadales, Lactobacillales and Bacillales. These groups harbor many “priority human pathogens,” several major plant pathogens, as well as other bacteria playing key roles in the dairy and agriculture industries. We will identify multiple reliable characteristics specific for different disease-causing as well as beneficial bacteria that are part of these large groups, thereby providing important means for discovering novel biochemical traits of these bacteria and improving the means for their identification. Additionally, an important objective of this proposal is to test/establish the proof of principle that the CSIs in protein structures can be targeted for development of novel cell-growth inhibitory compounds. The establishment of this concept can provide a vast resource of new classes of drugs/inhibitors targeting the CSI-containing organisms. Overall, the work proposed here should greatly advance our understanding of a number of important groups of microorganisms and the applications of these findings should lead to a significant reduction in the health, agricultural and economic burden caused by these bacteria.
微生物在生命的各个方面都有平板角色,包括氮的回收,氮,废物,生物修复,抗生素的产生和其他重要化合物,以及人类健康和疾病的主要决定因素。 ,捕鱼和其他地区,开发可靠的手段来区分女士的区分群体,但是,大多数细菌组目前仅在16S rRNA树中仅仅在其分支中彼此区分信息本身并不能为大多数特性或生化特性提供表型性状的预测。由特定组和CH共享的保守性状可以使用基因组序列来区分其他组。在特定的生物体中,基因型指定表型,这些分子标记将为每个生物体的生物化学/生物学特性提供了进口手段重要的细菌群体。 ,从而提供了重要的手段,以发现这些细菌的新生物化学特征并改善其识别手段。细胞增长抑制性化合物。这些细菌引起的健康,农业和经济负担很大。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gupta, Radhey其他文献
Gupta, Radhey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gupta, Radhey', 18)}}的其他基金
Applications of Genomics Derived Characteristics for Evolutionary and Functional studies and for Development of Novel Diagnostics and Therapeutics
基因组学衍生特征在进化和功能研究以及新型诊断和治疗方法开发中的应用
- 批准号:
RGPIN-2019-06397 - 财政年份:2022
- 资助金额:
$ 3.42万 - 项目类别:
Discovery Grants Program - Individual
Applications of Genomics Derived Characteristics for Evolutionary and Functional studies and for Development of Novel Diagnostics and Therapeutics
基因组学衍生特征在进化和功能研究以及新型诊断和治疗方法开发中的应用
- 批准号:
RGPIN-2019-06397 - 财政年份:2021
- 资助金额:
$ 3.42万 - 项目类别:
Discovery Grants Program - Individual
Applications of Genomics Derived Characteristics for Evolutionary and Functional studies and for Development of Novel Diagnostics and Therapeutics
基因组学衍生特征在进化和功能研究以及新型诊断和治疗方法开发中的应用
- 批准号:
RGPIN-2019-06397 - 财政年份:2020
- 资助金额:
$ 3.42万 - 项目类别:
Discovery Grants Program - Individual
Identification and Characterization of Novel Molecular Markers for the Proteobacteria (Beta and Gamma) and Firmicutes Phyla
变形菌门(β 和 γ)和厚壁菌门新型分子标记的鉴定和表征
- 批准号:
249924-2012 - 财政年份:2018
- 资助金额:
$ 3.42万 - 项目类别:
Discovery Grants Program - Individual
Identification and Characterization of Novel Molecular Markers for the Proteobacteria (Beta and Gamma) and Firmicutes Phyla
变形菌门(β 和 γ)和厚壁菌门新型分子标记的鉴定和表征
- 批准号:
249924-2012 - 财政年份:2015
- 资助金额:
$ 3.42万 - 项目类别:
Discovery Grants Program - Individual
Identification and Characterization of Novel Molecular Markers for the Proteobacteria (Beta and Gamma) and Firmicutes Phyla
变形菌门(β 和 γ)和厚壁菌门新型分子标记的鉴定和表征
- 批准号:
249924-2012 - 财政年份:2014
- 资助金额:
$ 3.42万 - 项目类别:
Discovery Grants Program - Individual
Identification and Characterization of Novel Molecular Markers for the Proteobacteria (Beta and Gamma) and Firmicutes Phyla
变形菌门(β 和 γ)和厚壁菌门新型分子标记的鉴定和表征
- 批准号:
249924-2012 - 财政年份:2013
- 资助金额:
$ 3.42万 - 项目类别:
Discovery Grants Program - Individual
Identification and Characterization of Novel Molecular Markers for the Proteobacteria (Beta and Gamma) and Firmicutes Phyla
变形菌门(β 和 γ)和厚壁菌门新型分子标记的鉴定和表征
- 批准号:
249924-2012 - 财政年份:2012
- 资助金额:
$ 3.42万 - 项目类别:
Discovery Grants Program - Individual
Applications of rare genomic changes for understanding cyanbacterial phylogeny and the plastids origin
罕见基因组变化在理解蓝细菌系统发育和质体起源中的应用
- 批准号:
249924-2007 - 财政年份:2011
- 资助金额:
$ 3.42万 - 项目类别:
Discovery Grants Program - Individual
Applications of rare genomic changes for understanding cyanbacterial phylogeny and the plastids origin
罕见基因组变化在理解蓝细菌系统发育和质体起源中的应用
- 批准号:
249924-2007 - 财政年份:2010
- 资助金额:
$ 3.42万 - 项目类别:
Discovery Grants Program - Individual
相似国自然基金
基于保护基因组学和生态建模的中华凤头燕鸥整合保护研究
- 批准号:32370545
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于功能基因组学联合激酶抑制剂筛选发现SRPK1调节宫颈癌放疗敏感性的功能及机制研究
- 批准号:82303661
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多模态影像基因组学的前列腺癌治疗决策关键信息技术研究
- 批准号:62371010
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
面向癌症预后预测的基因组学与病理图像表征及融合方法研究
- 批准号:62302201
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
叶蝉科系统发生基因组学及分类订正
- 批准号:32370493
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
TOPMed WGS and Molecular Epidemiology Analyses for Cardiac Hypertrophy Phenotypes
心脏肥大表型的 TOPMed WGS 和分子流行病学分析
- 批准号:
10930193 - 财政年份:2023
- 资助金额:
$ 3.42万 - 项目类别:
MYCN drives a ferroptotic vulnerability in neuroblastoma
MYCN 导致神经母细胞瘤铁死亡的脆弱性
- 批准号:
10736479 - 财政年份:2023
- 资助金额:
$ 3.42万 - 项目类别:
Epigenetic control of spermatogonial stem cell self-renewal
精原干细胞自我更新的表观遗传控制
- 批准号:
10656855 - 财政年份:2023
- 资助金额:
$ 3.42万 - 项目类别:
Targeting polo-like kinase for therapy of small cell lung cancer
靶向 Polo 样激酶治疗小细胞肺癌
- 批准号:
10503509 - 财政年份:2022
- 资助金额:
$ 3.42万 - 项目类别:
Applications of Genomics Derived Characteristics for Evolutionary and Functional studies and for Development of Novel Diagnostics and Therapeutics
基因组学衍生特征在进化和功能研究以及新型诊断和治疗方法开发中的应用
- 批准号:
RGPIN-2019-06397 - 财政年份:2022
- 资助金额:
$ 3.42万 - 项目类别:
Discovery Grants Program - Individual